# Effect of Autologous Ear Cartilage Micrografting in Knee Osteoarthritis

> **NCT07755579** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Regenera Activa Worldwide S.L.** · enrollment: 33 (actual)

## Conditions studied

- Osteoarthritis
- Osteoarthritis (OA) of the Knee
- Moderate Osteoarthritis

## Interventions

- **DEVICE:** Mytocel MSK - Autologous Ear Cartilage Micrografting

## Key facts

- **NCT ID:** NCT07755579
- **Lead sponsor:** Regenera Activa Worldwide S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-22
- **Primary completion:** 2025-12-21
- **Final completion:** 2027-12-21
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2026-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755579, "Effect of Autologous Ear Cartilage Micrografting in Knee Osteoarthritis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07755579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
